Close monitoring via weekly complete blood counts (CBCs) for the first 2 months is essential to mitigate risks, according to Zeidan. Supportive care such as platelet transfusions or growth factors may ...

Researchers from the Stephan Angeloff Institute of Microbiology have published new findings in Global Medical Genetics ...

King Faisal Specialist Hospital and Research Centre (KFSHRC) has reinforced its leading position in Saudi Arabia’s healthcare ...

SELLAS Life Sciences Group (SLS) announced on Monday that preclinical data support its SLS009 as a monotherapy or in combination with Venetoclax for treating a rare and highly aggressive form of ...

University of Cambridge scientists have used human stem cells to create three-dimensional embryo-like structures that ...

Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 ...

Study’s Dose Escalation Safety Committee approves initiation of Cohort 2 with fourth patient to receive increase in initial dose pending ...

The results highlight an in vivo patient-derived xenograft (PDX) model of relapsed/refractory T-PLL that reproduced key human clinicopathological features of the disease. In this model, SLS009 ...

Scientists at the University of Duisburg-Essen are researching new therapies for aggressive forms of childhood leukemia.

This weekend, Holyoke’s Paper City Food Festival is spotlighting local businesses while supporting a special cause: helping ...

The first week of May, Lindsey Warmouth got news that she was pregnant. In the third week, that her 8-year-old son had cancer ...